Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparison of 茚达格莫 inhalation powder versus Enzhuorun in Chinese adults with asthma
CTR20262104Phase 3Active
- Sponsor
- Qilu Antie Pharmaceutical
- Start
- Jun 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of indacaterol, glycopyrronium, mometasone in asthma, sponsored by Qilu Antie Pharmaceutical. Started Jun 2026; status: active.
02
Drugs
indacaterolglycopyrroniummometasone
03
Conditions
asthma
Beyond the preview
Go deeper on CTR20262104.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20262104.